Luteinizing hormone secretion and hypoandrogenaemia in critically ill men

Effect of dopamine

G. Van den Berghe, F. De Zeghert, P. Lauwers, Johannes D Veldhuis

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Objective: Critical illness has been associated with decreased LH secretion and lowering of testosterone. Dopamine is often used for vasoactive support in these patients. We therefore aimed to investigate LH secretion during severe illness and particularly the effect exerted by dopamine on LH in such patients. Patients and design: In a randomized, controlled study of critically ill adult male polytrauma patients (n = 9), we evaluated the effect of prolonged (83-296 hours) dopamine Infusion (5 μg/kg/min i.v.) on the dynamics of LH secretion and on serum testosterone concentrations. The effect of brief (15-21 hours) dopamine administration was documented in an additional randomized, controlled, crossover study involving 6 patients. Measurements: Serum LH concentrations were measured by IRMA. The LH profiles, obtained by blood sampling every 20 minutes for 9 hours during two consecutive nights, were examined by deconvolution analysis. Serum testosterone concentrations were measured by RIA once per study night. Results: We found that before dopamine initiation and within 24 hours of dopamine withdrawal, the mean serum LH concentrations, the LH secretory amplitude, the amount of LH secreted per burst, the mean LH secretion rate and the number of LH pulses were higher than during dopamine infusion, being increased by a median of 161% (P = 0.006), 98% (P = 0.03), 106% (P = 0.03), 164% (P = 0.01) and 25% (P = 0.008) respectively. However, without dopamine administration the amplitude and mass of the LH secretory bursts still appeared to be low, whereas the pulse frequency remained elevated. After dopamine withdrawal, LH secretion increased significantly within 3 hours. Serum testosterone levels were very low and dopamine infusion appeared not to affect them within 24 hours. Conclusion: We documented decreased LH secretory pulse amplitude and mass with increased pulse frequency, as well as very low serum testosterone concentrations in critically ill men. Dopamine infusion further suppressed LH release by decreasing secretory burst amplitude, mass and frequency, possibly through an inhibitory action at both the pituitary and the hypothalamic level.

Original languageEnglish (US)
Pages (from-to)563-569
Number of pages7
JournalClinical Endocrinology
Volume41
Issue number5
StatePublished - 1994
Externally publishedYes

Fingerprint

Luteinizing Hormone
Critical Illness
Dopamine
Testosterone
Serum
Multiple Trauma
Cross-Over Studies

ASJC Scopus subject areas

  • Endocrinology

Cite this

Van den Berghe, G., De Zeghert, F., Lauwers, P., & Veldhuis, J. D. (1994). Luteinizing hormone secretion and hypoandrogenaemia in critically ill men: Effect of dopamine. Clinical Endocrinology, 41(5), 563-569.

Luteinizing hormone secretion and hypoandrogenaemia in critically ill men : Effect of dopamine. / Van den Berghe, G.; De Zeghert, F.; Lauwers, P.; Veldhuis, Johannes D.

In: Clinical Endocrinology, Vol. 41, No. 5, 1994, p. 563-569.

Research output: Contribution to journalArticle

Van den Berghe, G, De Zeghert, F, Lauwers, P & Veldhuis, JD 1994, 'Luteinizing hormone secretion and hypoandrogenaemia in critically ill men: Effect of dopamine', Clinical Endocrinology, vol. 41, no. 5, pp. 563-569.
Van den Berghe G, De Zeghert F, Lauwers P, Veldhuis JD. Luteinizing hormone secretion and hypoandrogenaemia in critically ill men: Effect of dopamine. Clinical Endocrinology. 1994;41(5):563-569.
Van den Berghe, G. ; De Zeghert, F. ; Lauwers, P. ; Veldhuis, Johannes D. / Luteinizing hormone secretion and hypoandrogenaemia in critically ill men : Effect of dopamine. In: Clinical Endocrinology. 1994 ; Vol. 41, No. 5. pp. 563-569.
@article{38013f0699904580a3af470a9a7ad42b,
title = "Luteinizing hormone secretion and hypoandrogenaemia in critically ill men: Effect of dopamine",
abstract = "Objective: Critical illness has been associated with decreased LH secretion and lowering of testosterone. Dopamine is often used for vasoactive support in these patients. We therefore aimed to investigate LH secretion during severe illness and particularly the effect exerted by dopamine on LH in such patients. Patients and design: In a randomized, controlled study of critically ill adult male polytrauma patients (n = 9), we evaluated the effect of prolonged (83-296 hours) dopamine Infusion (5 μg/kg/min i.v.) on the dynamics of LH secretion and on serum testosterone concentrations. The effect of brief (15-21 hours) dopamine administration was documented in an additional randomized, controlled, crossover study involving 6 patients. Measurements: Serum LH concentrations were measured by IRMA. The LH profiles, obtained by blood sampling every 20 minutes for 9 hours during two consecutive nights, were examined by deconvolution analysis. Serum testosterone concentrations were measured by RIA once per study night. Results: We found that before dopamine initiation and within 24 hours of dopamine withdrawal, the mean serum LH concentrations, the LH secretory amplitude, the amount of LH secreted per burst, the mean LH secretion rate and the number of LH pulses were higher than during dopamine infusion, being increased by a median of 161{\%} (P = 0.006), 98{\%} (P = 0.03), 106{\%} (P = 0.03), 164{\%} (P = 0.01) and 25{\%} (P = 0.008) respectively. However, without dopamine administration the amplitude and mass of the LH secretory bursts still appeared to be low, whereas the pulse frequency remained elevated. After dopamine withdrawal, LH secretion increased significantly within 3 hours. Serum testosterone levels were very low and dopamine infusion appeared not to affect them within 24 hours. Conclusion: We documented decreased LH secretory pulse amplitude and mass with increased pulse frequency, as well as very low serum testosterone concentrations in critically ill men. Dopamine infusion further suppressed LH release by decreasing secretory burst amplitude, mass and frequency, possibly through an inhibitory action at both the pituitary and the hypothalamic level.",
author = "{Van den Berghe}, G. and {De Zeghert}, F. and P. Lauwers and Veldhuis, {Johannes D}",
year = "1994",
language = "English (US)",
volume = "41",
pages = "563--569",
journal = "Clinical Endocrinology",
issn = "0300-0664",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Luteinizing hormone secretion and hypoandrogenaemia in critically ill men

T2 - Effect of dopamine

AU - Van den Berghe, G.

AU - De Zeghert, F.

AU - Lauwers, P.

AU - Veldhuis, Johannes D

PY - 1994

Y1 - 1994

N2 - Objective: Critical illness has been associated with decreased LH secretion and lowering of testosterone. Dopamine is often used for vasoactive support in these patients. We therefore aimed to investigate LH secretion during severe illness and particularly the effect exerted by dopamine on LH in such patients. Patients and design: In a randomized, controlled study of critically ill adult male polytrauma patients (n = 9), we evaluated the effect of prolonged (83-296 hours) dopamine Infusion (5 μg/kg/min i.v.) on the dynamics of LH secretion and on serum testosterone concentrations. The effect of brief (15-21 hours) dopamine administration was documented in an additional randomized, controlled, crossover study involving 6 patients. Measurements: Serum LH concentrations were measured by IRMA. The LH profiles, obtained by blood sampling every 20 minutes for 9 hours during two consecutive nights, were examined by deconvolution analysis. Serum testosterone concentrations were measured by RIA once per study night. Results: We found that before dopamine initiation and within 24 hours of dopamine withdrawal, the mean serum LH concentrations, the LH secretory amplitude, the amount of LH secreted per burst, the mean LH secretion rate and the number of LH pulses were higher than during dopamine infusion, being increased by a median of 161% (P = 0.006), 98% (P = 0.03), 106% (P = 0.03), 164% (P = 0.01) and 25% (P = 0.008) respectively. However, without dopamine administration the amplitude and mass of the LH secretory bursts still appeared to be low, whereas the pulse frequency remained elevated. After dopamine withdrawal, LH secretion increased significantly within 3 hours. Serum testosterone levels were very low and dopamine infusion appeared not to affect them within 24 hours. Conclusion: We documented decreased LH secretory pulse amplitude and mass with increased pulse frequency, as well as very low serum testosterone concentrations in critically ill men. Dopamine infusion further suppressed LH release by decreasing secretory burst amplitude, mass and frequency, possibly through an inhibitory action at both the pituitary and the hypothalamic level.

AB - Objective: Critical illness has been associated with decreased LH secretion and lowering of testosterone. Dopamine is often used for vasoactive support in these patients. We therefore aimed to investigate LH secretion during severe illness and particularly the effect exerted by dopamine on LH in such patients. Patients and design: In a randomized, controlled study of critically ill adult male polytrauma patients (n = 9), we evaluated the effect of prolonged (83-296 hours) dopamine Infusion (5 μg/kg/min i.v.) on the dynamics of LH secretion and on serum testosterone concentrations. The effect of brief (15-21 hours) dopamine administration was documented in an additional randomized, controlled, crossover study involving 6 patients. Measurements: Serum LH concentrations were measured by IRMA. The LH profiles, obtained by blood sampling every 20 minutes for 9 hours during two consecutive nights, were examined by deconvolution analysis. Serum testosterone concentrations were measured by RIA once per study night. Results: We found that before dopamine initiation and within 24 hours of dopamine withdrawal, the mean serum LH concentrations, the LH secretory amplitude, the amount of LH secreted per burst, the mean LH secretion rate and the number of LH pulses were higher than during dopamine infusion, being increased by a median of 161% (P = 0.006), 98% (P = 0.03), 106% (P = 0.03), 164% (P = 0.01) and 25% (P = 0.008) respectively. However, without dopamine administration the amplitude and mass of the LH secretory bursts still appeared to be low, whereas the pulse frequency remained elevated. After dopamine withdrawal, LH secretion increased significantly within 3 hours. Serum testosterone levels were very low and dopamine infusion appeared not to affect them within 24 hours. Conclusion: We documented decreased LH secretory pulse amplitude and mass with increased pulse frequency, as well as very low serum testosterone concentrations in critically ill men. Dopamine infusion further suppressed LH release by decreasing secretory burst amplitude, mass and frequency, possibly through an inhibitory action at both the pituitary and the hypothalamic level.

UR - http://www.scopus.com/inward/record.url?scp=0027988185&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027988185&partnerID=8YFLogxK

M3 - Article

VL - 41

SP - 563

EP - 569

JO - Clinical Endocrinology

JF - Clinical Endocrinology

SN - 0300-0664

IS - 5

ER -